Protective effect of ZYMT, a traditional Chinese patent medicine in a mouse model of retinitis pigmentosa

Retinitis pigmentosa (RP) is the most common genetic disorder that causes blindness. At present, there exists no remedy for the disease. The aim of the current research was to investigate the protective effect of Zhangyanming Tablets (ZYMT) in a mouse model of RP, and explore the underlying mechanis...

Full description

Bibliographic Details
Main Authors: Ziyang Huang, Qiuling Huang, Kai Xu, Lina Liang, Yamin Li, Wei Zhou, Na Ning, Jiewen Zhou, Jiajia Hu, Shanshan Liu, Lei Dang
Format: Article
Language:English
Published: Elsevier 2023-06-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332223003682
_version_ 1797837182311858176
author Ziyang Huang
Qiuling Huang
Kai Xu
Lina Liang
Yamin Li
Wei Zhou
Na Ning
Jiewen Zhou
Jiajia Hu
Shanshan Liu
Lei Dang
author_facet Ziyang Huang
Qiuling Huang
Kai Xu
Lina Liang
Yamin Li
Wei Zhou
Na Ning
Jiewen Zhou
Jiajia Hu
Shanshan Liu
Lei Dang
author_sort Ziyang Huang
collection DOAJ
description Retinitis pigmentosa (RP) is the most common genetic disorder that causes blindness. At present, there exists no remedy for the disease. The aim of the current research was to investigate the protective effect of Zhangyanming Tablets (ZYMT) in a mouse model of RP, and explore the underlying mechanism. Eighty RP mice were randomly divided into two groups. The mice in ZYMT group were administered with ZYMT suspension(0.0378 g/mL), while the mice in model group were given the same volume of distilled water. At day 7 and day 14 after intervention, electroretinogram (ERG), fundus photography, and histological examination were used to assess the retinal function and structure. TUNEL, immunofluorescence and qPCR were used to evaluate cell apoptosis and expressions of Sirt1, Iba1, Bcl-2, Bax and Caspase-3. A significantly shortened latency of ERG waves was observed in ZYMT-treated mice, in comparison to those in the model group (P < 0.05). Histologically, ultrastructure of the retina was better preserved, and the outer nuclear layer (ONL) exhibited marked increase in thickness and cell count in ZYMP group (P < 0.05). The apoptosis rate was decreased markedly in ZYMT group. Immunofluorescence analysis showed that the expressions of Iba1 and Bcl-2 in the retina were increased, Bax and Caspase-3 were decreased after ZYMT intervention, while the qPCR revealed that the expressions of Iba1 and Sirt1 were significantly increased (P < 0.05). This study indicated that ZYMT has protective effect on retinal function and morphology of inherited RP mice in the early stage, possibly mediated via the regulation of antioxidant and anti-/pro-apoptotic factors expressions.
first_indexed 2024-04-09T15:21:19Z
format Article
id doaj.art-a11065de62b04cfca3e634846f56793e
institution Directory Open Access Journal
issn 0753-3322
language English
last_indexed 2024-04-09T15:21:19Z
publishDate 2023-06-01
publisher Elsevier
record_format Article
series Biomedicine & Pharmacotherapy
spelling doaj.art-a11065de62b04cfca3e634846f56793e2023-04-29T14:45:53ZengElsevierBiomedicine & Pharmacotherapy0753-33222023-06-01162114580Protective effect of ZYMT, a traditional Chinese patent medicine in a mouse model of retinitis pigmentosaZiyang Huang0Qiuling Huang1Kai Xu2Lina Liang3Yamin Li4Wei Zhou5Na Ning6Jiewen Zhou7Jiajia Hu8Shanshan Liu9Lei Dang10Eye Hospital, China Academy of Chinese Medical Sciences, Beijing, ChinaGuangdong Development Engineering Laboratory of Southern Chinese Herbal Drugs, Guangzhou, ChinaEye Hospital, China Academy of Chinese Medical Sciences, Beijing, ChinaEye Hospital, China Academy of Chinese Medical Sciences, Beijing, China; Correspondence to: Eye Hospital, China Academy of Chinese Medical Sciences, Beijing 100040, China.Eye Hospital, China Academy of Chinese Medical Sciences, Beijing, ChinaEye Hospital, China Academy of Chinese Medical Sciences, Beijing, ChinaGuangdong Development Engineering Laboratory of Southern Chinese Herbal Drugs, Guangzhou, ChinaGuangdong Development Engineering Laboratory of Southern Chinese Herbal Drugs, Guangzhou, ChinaGuangdong Development Engineering Laboratory of Southern Chinese Herbal Drugs, Guangzhou, ChinaGuangdong Development Engineering Laboratory of Southern Chinese Herbal Drugs, Guangzhou, ChinaGuangdong Development Engineering Laboratory of Southern Chinese Herbal Drugs, Guangzhou, ChinaRetinitis pigmentosa (RP) is the most common genetic disorder that causes blindness. At present, there exists no remedy for the disease. The aim of the current research was to investigate the protective effect of Zhangyanming Tablets (ZYMT) in a mouse model of RP, and explore the underlying mechanism. Eighty RP mice were randomly divided into two groups. The mice in ZYMT group were administered with ZYMT suspension(0.0378 g/mL), while the mice in model group were given the same volume of distilled water. At day 7 and day 14 after intervention, electroretinogram (ERG), fundus photography, and histological examination were used to assess the retinal function and structure. TUNEL, immunofluorescence and qPCR were used to evaluate cell apoptosis and expressions of Sirt1, Iba1, Bcl-2, Bax and Caspase-3. A significantly shortened latency of ERG waves was observed in ZYMT-treated mice, in comparison to those in the model group (P < 0.05). Histologically, ultrastructure of the retina was better preserved, and the outer nuclear layer (ONL) exhibited marked increase in thickness and cell count in ZYMP group (P < 0.05). The apoptosis rate was decreased markedly in ZYMT group. Immunofluorescence analysis showed that the expressions of Iba1 and Bcl-2 in the retina were increased, Bax and Caspase-3 were decreased after ZYMT intervention, while the qPCR revealed that the expressions of Iba1 and Sirt1 were significantly increased (P < 0.05). This study indicated that ZYMT has protective effect on retinal function and morphology of inherited RP mice in the early stage, possibly mediated via the regulation of antioxidant and anti-/pro-apoptotic factors expressions.http://www.sciencedirect.com/science/article/pii/S0753332223003682Retinitis pigmentosaChinese patent medicinesCell apoptosisMechanism
spellingShingle Ziyang Huang
Qiuling Huang
Kai Xu
Lina Liang
Yamin Li
Wei Zhou
Na Ning
Jiewen Zhou
Jiajia Hu
Shanshan Liu
Lei Dang
Protective effect of ZYMT, a traditional Chinese patent medicine in a mouse model of retinitis pigmentosa
Biomedicine & Pharmacotherapy
Retinitis pigmentosa
Chinese patent medicines
Cell apoptosis
Mechanism
title Protective effect of ZYMT, a traditional Chinese patent medicine in a mouse model of retinitis pigmentosa
title_full Protective effect of ZYMT, a traditional Chinese patent medicine in a mouse model of retinitis pigmentosa
title_fullStr Protective effect of ZYMT, a traditional Chinese patent medicine in a mouse model of retinitis pigmentosa
title_full_unstemmed Protective effect of ZYMT, a traditional Chinese patent medicine in a mouse model of retinitis pigmentosa
title_short Protective effect of ZYMT, a traditional Chinese patent medicine in a mouse model of retinitis pigmentosa
title_sort protective effect of zymt a traditional chinese patent medicine in a mouse model of retinitis pigmentosa
topic Retinitis pigmentosa
Chinese patent medicines
Cell apoptosis
Mechanism
url http://www.sciencedirect.com/science/article/pii/S0753332223003682
work_keys_str_mv AT ziyanghuang protectiveeffectofzymtatraditionalchinesepatentmedicineinamousemodelofretinitispigmentosa
AT qiulinghuang protectiveeffectofzymtatraditionalchinesepatentmedicineinamousemodelofretinitispigmentosa
AT kaixu protectiveeffectofzymtatraditionalchinesepatentmedicineinamousemodelofretinitispigmentosa
AT linaliang protectiveeffectofzymtatraditionalchinesepatentmedicineinamousemodelofretinitispigmentosa
AT yaminli protectiveeffectofzymtatraditionalchinesepatentmedicineinamousemodelofretinitispigmentosa
AT weizhou protectiveeffectofzymtatraditionalchinesepatentmedicineinamousemodelofretinitispigmentosa
AT naning protectiveeffectofzymtatraditionalchinesepatentmedicineinamousemodelofretinitispigmentosa
AT jiewenzhou protectiveeffectofzymtatraditionalchinesepatentmedicineinamousemodelofretinitispigmentosa
AT jiajiahu protectiveeffectofzymtatraditionalchinesepatentmedicineinamousemodelofretinitispigmentosa
AT shanshanliu protectiveeffectofzymtatraditionalchinesepatentmedicineinamousemodelofretinitispigmentosa
AT leidang protectiveeffectofzymtatraditionalchinesepatentmedicineinamousemodelofretinitispigmentosa